Management of Low Anterior Resection Syndrome (LARS) Following Resection for Rectal Cancer
- PMID: 36765736
- PMCID: PMC9913853
- DOI: 10.3390/cancers15030778
Management of Low Anterior Resection Syndrome (LARS) Following Resection for Rectal Cancer
Abstract
Introduction: A total of 60-80% of patients undergoing rectal resection (mostly as a treatment for rectal cancer) suffer from a variety of partly severe functional problems despite preservation of the anal sphincter. These patients are summarized under the term low anterior resection syndrome (LARS). Preoperative radiotherapy, vascular dissection and surgical excision of the low rectum and mesorectum lead, alone or all together, to a significant impairment of colonic and (neo-) rectal motility. This results in a variety of symptoms (multiple defecation episodes, recurrent episodes of urge, clustering, incontinence, etc.) which are associated with severe impairment of quality of life (QOL).
Methods: This narrative review summarizes the present state of knowledge regarding the pathophysiology of LARS as well as the evidence for the available treatment options to control the symptoms resulting from this condition.
Results: A review of the literature (Medline, Pubmed) reveals a variety of treatment options available to control symptoms of LARS. Medical therapy, with or without dietary modification, shows only a modest effect. Pelvic floor rehabilitation consisting of muscle exercise techniques as well as biofeedback training has been associated with improvement in LARS scores and incontinence, albeit with limited scientific evidence. Transanal irrigation (TAI) has gained interest as a treatment modality for patients with LARS due to an increasing number of promising data from recently published studies. Despite this promising observation, open questions about still-unclear issues of TAI remain under debate. Neuromodulation has been applied in LARS only in a few studies with small numbers of patients and partly conflicting results.
Conclusion: LARS is a frequent problem after sphincter-preserving rectal surgery and leads to a marked impairment of QOL. Due to the large number of patients suffering from this condition, mandatory identification, as well as treatment of affected patients, must be considered during surgical as well as oncological follow-up. The use of a standardized treatment algorithm will lead to sufficient control of symptoms and a high probability of a marked improvement in QOL.
Keywords: low anterior resection syndrome; rectal resection; transanal irrigation.
Conflict of interest statement
H.R. is member of the Advisory Board for LARS of Coloplast. Coloplast was not financially involved in the production of this article. Other authors declare no conflict of interest.
Figures
Similar articles
-
Pathway Of Low Anterior Resection syndrome (LARS) relief after Surgery (POLARiS): protocol for an international, open-label, multi-arm, phase 3 randomised superiority trial within a cohort, with economic evaluation, process evaluation and qualitative sub-study, to explore the natural history of LARS and compare transanal irrigation and sacral neuromodulation to optimised conservative management for people with major LARS following a high or low anterior resection for colorectal cancer.BMJ Open. 2025 Feb 3;15(2):e092612. doi: 10.1136/bmjopen-2024-092612. BMJ Open. 2025. PMID: 39900423 Free PMC article.
-
A Randomized Controlled Clinical Trial of Transanal Irrigation Versus Conservative Treatment in Patients With Low Anterior Resection Syndrome After Rectal Cancer Surgery.Ann Surg. 2023 Jan 1;277(1):30-37. doi: 10.1097/SLA.0000000000005482. Epub 2022 Jul 7. Ann Surg. 2023. PMID: 35797618 Clinical Trial.
-
[Intervention effect of biofeedback combined with pelvic floor muscle exercise on low anterior resection syndrome in patients with low anus-preserving rectal cancer].Zhonghua Yi Xue Za Zhi. 2019 Aug 13;99(30):2337-2343. doi: 10.3760/cma.j.issn.0376-2491.2019.30.004. Zhonghua Yi Xue Za Zhi. 2019. PMID: 31434413 Clinical Trial. Chinese.
-
Systematic review of the management options available for low anterior resection syndrome (LARS).Tech Coloproctol. 2025 Feb 4;29(1):58. doi: 10.1007/s10151-024-03090-3. Tech Coloproctol. 2025. PMID: 39903381
-
A Systematic Review of Comparative Effectiveness of Interventions for Low Anterior Resection Syndrome: Impacts on Bowel Function and Quality of Life.Cureus. 2024 Oct 31;16(10):e72772. doi: 10.7759/cureus.72772. eCollection 2024 Oct. Cureus. 2024. PMID: 39483606 Free PMC article. Review.
Cited by
-
High output stoma after surgery for rectal cancer - a risk factor for low anterior resection syndrome?BMC Gastroenterol. 2025 Jan 23;25(1):32. doi: 10.1186/s12876-025-03614-7. BMC Gastroenterol. 2025. PMID: 39849372 Free PMC article.
-
Therapeutic strategies for low anterior resection syndrome: an umbrella review of systematic reviews.Int J Colorectal Dis. 2025 Aug 5;40(1):171. doi: 10.1007/s00384-025-04965-z. Int J Colorectal Dis. 2025. PMID: 40762861 Free PMC article. Review.
-
Risk factors for severe low anterior resection syndrome in patients with rectal cancer undergoing sphincter‑preserving resection: A systematic review and meta‑analysis.Oncol Lett. 2023 Nov 22;27(1):30. doi: 10.3892/ol.2023.14163. eCollection 2024 Jan. Oncol Lett. 2023. PMID: 38108080 Free PMC article.
-
Research on preventing low anterior resection syndrome following sphincter-preserving surgery for rectal cancer through high-risk screening and pelvic floor biofeedback therapy.Support Care Cancer. 2025 Mar 17;33(4):291. doi: 10.1007/s00520-025-09358-0. Support Care Cancer. 2025. PMID: 40095142
-
Clinical Outcomes of Ileostomy Closure during versus after Adjuvant Chemotherapy in Patients with Rectal Cancer.Can J Gastroenterol Hepatol. 2024 Mar 20;2024:2410643. doi: 10.1155/2024/2410643. eCollection 2024. Can J Gastroenterol Hepatol. 2024. PMID: 38550348 Free PMC article.
References
-
- Kong J.C., Soucisse M., Michael M., Tie J., Ngan S.Y., Leong T., McCormick J., Warrier S.K., Heriot A.G. Total neoadjuvant therapy in locally advanced rectal cancer: A systematic review and metaanalysis of oncological and operative outcomes. Ann. Surg. Oncol. 2021;28:7476–7486. doi: 10.1245/s10434-021-09837-8. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources